Dr Tavoularis was diagnosed with multiple myeloma in January 2014. That same year, she retired from the Canadian Blood Services, where she held the position of Director of the HLA Laboratory. In that position, she was responsible for the provision of large-scale HLA genotyping services for donors across the country (except Quebec- who joined the Canadian OneMatch Stem Cell and Marrow Network).
Dr Tavoularis has a range of expertise in the areas of histocompatibility and immunogenetics, molecular biology and immunohematology, as well as extensive experience in HLA typing. Her work in sequence-based typing led to the identification of 37 new alleles, which were reported to the HLA WHO Nomenclature Committee.
In addition to Dr Tavoularis’ position as Patient Representative of the Myeloma Canada Research Network (MCRN) Board of Directors, she is also a member of the MCRN project Review Committee and a member of Myeloma Canada, Ontario Advisory Committee.
Dr Tavoularis received her PhD in Immunogenetics from The Johns Hopkins University, followed by a Postdoctoral Fellowship at the Department of Medicine at the University of Ottawa. She has published over 120 full papers.